J S Ross Selected Research

osimertinib

1/2017

Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J S Ross Research Topics

Disease

32	Neoplasms (Cancer) 12/2023 - 01/2000
6	Carcinoma (Carcinomatosis) 10/2021 - 06/2001
6	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2001
6	Adenocarcinoma 01/2006 - 01/2000
5	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2000
5	Shock 06/2018 - 08/2013
4	Microsatellite Instability 12/2023 - 05/2001
3	Carcinogenesis 11/2023 - 06/2001
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2003
3	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2006
3	Multiple Myeloma 10/2014 - 11/2001
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2006 - 04/2000
3	Prostatic Neoplasms (Prostate Cancer) 11/2005 - 08/2001
2	Disease Progression 12/2020 - 12/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2001
2	Melanoma (Melanoma, Malignant) 09/2006 - 05/2000
2	Atherosclerotic Plaque (Atheroma) 12/2001 - 12/2001
2	Aneuploidy (Aneuploid) 12/2001 - 06/2001
2	Hemorrhage 12/2001 - 12/2001
2	Thrombosis (Thrombus) 12/2001 - 12/2001
2	Hypersensitivity (Allergy) 08/2001 - 02/2001
2	Lymphatic Metastasis 07/2001 - 05/2000
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2001 - 01/2001
1	Pathologic Complete Response 12/2020
1	Adenocarcinoma of Lung 01/2017
1	Mucoepidermoid Carcinoma 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 01/2016
1	Eosinophilia 02/2015
1	Adrenocortical Carcinoma 11/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2014
1	Ovarian Epithelial Carcinoma 09/2013
1	Alzheimer Disease (Alzheimer's Disease) 03/2013
1	Insulin Resistance 01/2013
1	Metabolic Diseases (Metabolic Disease) 01/2013
1	Obesity 01/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2005 - 01/2000
7	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 05/2001
6	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2001
5	ParaffinIBA 11/2023 - 05/2000
5	Estrogen ReceptorsIBA 01/2019 - 05/2000
4	Formaldehyde (Formol)FDA Link 11/2023 - 05/2000
4	Cadherins (E-Cadherin)IBA 01/2003 - 08/2001
4	CateninsIBA 01/2003 - 08/2001
4	Cell Adhesion MoleculesIBA 12/2001 - 05/2001
3	PlatinumIBA 11/2023 - 12/2020
3	Circulating Tumor DNAIBA 12/2020 - 01/2017
3	pembrolizumabIBA 12/2020 - 01/2019
2	CarbonIBA 06/2018 - 11/2016
2	Protons (Proton)IBA 03/2018 - 11/2016
2	DeuteriumIBA 11/2016 - 08/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2006 - 10/2001
2	Bortezomib (Velcade)FDA Link 05/2005 - 11/2001
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2005 - 11/2001
2	Proteasome InhibitorsIBA 05/2005 - 11/2001
2	beta CateninIBA 01/2003 - 12/2001
2	Delta CateninIBA 12/2001 - 08/2001
2	Angiogenesis Modulating AgentsIBA 12/2001 - 12/2001
2	Peptide Hydrolases (Proteases)FDA Link 12/2001 - 12/2001
2	LigandsIBA 12/2001 - 12/2001
2	Growth Factor ReceptorsIBA 12/2001 - 12/2001
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2001 - 05/2001
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2001 - 05/2000
2	trioctyl phosphine oxide (TOPO)IBA 05/2000 - 05/2000
1	Codon (Codons)IBA 11/2023
1	durvalumabIBA 10/2021
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021
1	cabozantinibIBA 10/2021
1	130-nm albumin-bound paclitaxelIBA 12/2020
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	UraniumIBA 06/2018
1	HeliumIBA 06/2018
1	HydrogenIBA 03/2018
1	IonsIBA 03/2018
1	osimertinibIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Everolimus FDA Link 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 02/2015
1	VemurafenibIBA 10/2014
1	IceIBA 08/2013
1	Capsules (Microcapsules)IBA 08/2013
1	TritiumIBA 08/2013
1	florbetapirIBA 03/2013
1	Amyloid (Amyloid Fibrils)IBA 03/2013
1	SphingolipidsIBA 01/2013
1	Messenger RNA (mRNA)IBA 09/2006
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2006
1	AntibodiesIBA 01/2006

Therapy/Procedure

13	Therapeutics 11/2023 - 01/2001
3	Drug Therapy (Chemotherapy) 11/2023 - 05/2000
3	Lasers (Laser) 06/2018 - 02/2015
2	Ligation 10/2017 - 01/2017
1	Immunotherapy 11/2023
1	Neoadjuvant Therapy 12/2020
1	Salvage Therapy 12/2020
1	Cystectomy 12/2020